|
WO2021043926A1
|
|
Manganese chelate isomers
|
|
US2021030878A1
|
|
Novel formulation and method of synthesis
|
|
GB201919016D0
|
|
Apparatus and method for solid phase extraction
|
|
GB201915206D0
|
|
Use of cyclodextrins as a radiostabilizer
|
|
CN112154131A
|
|
Stabilized radiolabelling reactions
|
|
US2020211678A1
|
|
Automated image quality control apparatus and methods
|
|
US2020143937A1
|
|
Systems and methods for distributed ledger management of nuclear medicine products
|
|
KR20200102416A
|
|
Medical system for diagnosing cognitive disease lesions and/or course
|
|
GB201805283D0
|
|
Method of synthesizing a radiopharmaceutical
|
|
WO2018115148A1
|
|
Differential diagnosis of parkinson's disease
|
|
CN109415312A
|
|
Alkylation
|
|
GB201621864D0
|
|
Solid phase conditioning
|
|
EP3367992A1
|
|
Shielding device
|
|
US2016376265A1
|
|
Preparation of n-monofluoroalkyl compounds
|
|
WO2016188965A1
|
|
Risk stratification
|
|
WO2016097355A1
|
|
Labelled oxazolidinone derivatives
|
|
WO2016097345A1
|
|
Labelled chromone derivatives
|
|
WO2016097339A1
|
|
Labelled coumarin derivatives
|
|
WO2016097351A1
|
|
18f labelled thiazolylhydrazone derivatives
|
|
KR20170093132A
|
|
Method of removing acetaldehyde from radioactive pharmaceuticals
|
